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Cervical cancer is a leading cancer among women in developing countries. Infection with oncogenic human papillomavirus
(HPV) types has been recognized as a necessary cause of this disease. Serum carotenoids and tocopherols have also been
associated with risk for cervical neoplasia, but results from previous studies were not consistent. We evaluated the
association of serum total carotene and tocopherols, and dietary intakes with the risk of newly diagnosed, histologically
confirmed cervical intraepithelial neoplasia (CIN) grades 1, 2, 3 and invasive cancer in a hospital-based case-control study in
São Paulo, Brazil. The investigation included 453 controls and 4 groups of cases (CIN1, n 5 140; CIN2, n 5 126; CIN3, n 5
231; invasive cancer, n 5108) recruited from two major public clinics between 2003 and 2005. Increasing concentrations of
serum lycopene were negatively associated with CIN1, CIN3 and cancer, with odds ratios (OR) (95% CI) for the highest
compared to the lowest tertile of 0.53 (0.27–1.00, p for trend 5 0.05), 0.48 (0.22–1.04, p for trend 5 0.05) and 0.18 (0.06–
0.52, p for trend 5 0.002), respectively, after adjusting for confounding variables and HPV status. Increasing concentrations
of serum a- and c-tocopherols, and higher dietary intakes of dark green and deep yellow vegetables/fruit were associated
with nearly 50% decreased risk of CIN3. These results support the evidence that a healthy and balanced diet leading to
provide high serum levels of antioxidants may reduce cervical neoplasia risk in low-income women.
Cervical cancer is the second most common cancer among
women worldwide. Disease occurrence varies widely by geo-
graphic region, with the highest rates in Latin American
countries and the Caribbean, sub-Sahara Africa and parts
of Asia.1 Infection with oncogenic human papillomavirus
(HPV) types is considered a necessary cause in the develop-
ment of cervical cancer, and cofactors are tobacco smoking,
long-term oral contraceptive use and high parity.2–7
The aforementioned associations notwithstanding, the
results on the relationship of nutritional factors to cervical
neoplasia have not been consistent across different studies.
Only a few investigations have used large numbers of subjects
but were conducted mostly in developed countries. An im-
portant limitation is the absence of valid information on
HPV status and distribution of types, which varies by coun-
try.8 Thus, it has been suggested that most of the observa-
tions to date must be accepted only tentatively.9 The study of
the relationship of nutritional factors with cervical neoplasia
is complicated by its multifactorial etiology, with many of the
identified risk factors being correlated with nutritional and
socioeconomic status.10 Dietary components may be involved
in the etiology of this disease since socioeconomic differences
in risk persist after adjustment for known factors which sug-
gests that dietary inadequacy consequent to poverty may help
explain the high incidence rates in developing countries.11
Previous case-control studies carried out in developed
countries examined the association of carotenoids (a-caro-
tene, b-carotene, lycopene, lutein, cryptoxanthin), tocopherols
and retinol in both cervical cancer and preneoplastic lesions.
Although substantial evidence suggests a role for nutritional
factors in the persistence or clearance of HPV infection and
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the development of cervical cancer, most studies either did
not include valid information on habitual diet or did not
examine associations across the spectrum of preinvasive
lesion grades and cervical cancer.12–18
The objective of the present case-control study was to
examine associations between serum total carotene and toco-
pherols as well as dietary intakes on cervical intraepithelial




This case-control study included women attending 2 major
hospitals [Instituto Brasileiro de Controle do Câncer (IBCC)
and Hospital Perola Byington (HPB)] in São Paulo, Brazil,
for cervical cytological screening between 2003 and 2005.
IBCC and HPB are important public hospitals in the state of
São Paulo: the former for cancer screening and treatment,
and the latter as women’s tertiary care center. We aimed to
recruit prospectively newly diagnosed cases of CIN and inva-
sive cancer. Eligible women were residents of São Paulo aged
21–65 years and had no prior hysterectomy, previous treat-
ment for cervical neoplasia or cancer history. Women who
were positive for Human Immunodeficiency Virus (HIV) or
who had been pregnant or breastfeeding within 6 months of
enrollment were ineligible. Patients who had been in radio-
therapy or chemotherapy treatment were excluded because of
the concern that cancer treatment could have affected the
nutrients under investigation.
Cases included women with a histological diagnosis of
CIN grades 1, 2 or 3 or invasive adenocarcinoma, adenosqua-
mous or squamous cell carcinoma of the cervix, reviewed by
2 pathologists. During the same period, control women were
selected from among those attending routine cervical screen-
ing or those referred for cytology confirmation at the same
clinics where cases were diagnosed. All eligible women with a
cytological diagnosis within normal limits were invited to
participate.
Ethical approval was obtained from the Institutional
Review Boards of the School of Public Health (University of
São Paulo) and the Medical Ethical Committees of participat-
ing hospitals, and all participants provided written informed
consent.
Data collection
Participants underwent a personal interview by trained dieti-
tians blinded to the group assignment. A standardized ques-
tionnaire was used to elicit information on socioeconomic
and demographic characteristics, food intake, physical activity
(including both occupational and leisure activities, expressed
in metabolic equivalent tasks in hour per week), smoking
(individuals who had quit smoking at least 1 year before the
interview were considered former smoker) and alcohol con-
sumption, reproductive and sexual history, and other risk fac-
tors for cervical neoplasia. Self-reported ethnicity was defined
in 5 categories used by the Instituto Brasileiro de Geografia e
Estatı́stica: white, black, oriental, mulatto or Indian.
Body mass index (BMI) was calculated (kg/m2) based on
weight and height measurements with subjects wearing light
clothes and no shoes, according to standard protocols and
cut-offs proposed by the World Health Organization.19
Food consumption was assessed using a food frequency
questionnaire (FFQ) previously validated20,21 and adapted to
epidemiological studies on diet and prevention of chronic
diseases in São Paulo.22 Women were asked about usual fre-
quency of consumption of 76 foods items and their portion
sizes, an open-ended food section, and vitamin and mineral
supplements during the previous year. Nutrient and food
groups were analyzed using the Dietsys software version
4.01.23 The nutrient database was based primarily on the US
Department of Agriculture publications supplied by Dietsys
and supplemented by the Brazilian Standard Food Composi-
tion table. Questionnaires were excluded from further analy-
ses if energy intake was implausible (<700 or >6,000 Kcal/
day), corresponding to the percentiles <2.5 or >97.5, respec-
tively). For the present study, we investigated macronutrients,
vitamins, minerals and 5 food groups: (i) Dark green and
deep yellow vegetables and fruit (green salad, kale, broccoli,
spinach, pumpkin, carrot, sweet potatoes, papaya and
mango); (ii) total fruit and juices; (iii) only citrus fruit and
juices; (iv) total vegetables; (v) total fruit and vegetables.
Serum micronutrient analyses
All participants were scheduled to provide a fasting blood
sample within one-week after recruitment in the study.
Whole blood was taken protected from light, centrifuged
within 1 hr of collection and frozen at 70C until being an-
alyzed. Serum samples were analyzed for total carotene (a-,
b- and c-carotene), lycopene, a- and c- tocopherols and reti-
nol by reversed-phase high-performance liquid chromatogra-
phy (HP-1100 HPLC system, Hewlett Packard, Palo Alto,
CA), as previously described.24 Peaks for total carotene that
were under the quantification limits were set to zero. There
were 3 samples for total carotene, 1 for lycopene and 2 for c-
tocopherol that were below the limit of quantification (detect-
able level of total carotene, lycopene and c-tocopherol were
respectively: 0.5, 0.2 and 0.2 lmol/l). Total serum cholesterol
was measured enzymatically using an automatic device
(ADVIA 1650, Bayer, East Walpole, MA). All samples were
analyzed within 6 months after collection. The laboratory
assayed internal and external blinded quality control speci-
mens in every run. From the control specimens, the accuracy
and interassay coefficients of variation for these analytes were
within 8%.
HPV testing
Exfoliated cervical cells were collected from each woman
using the DNA-CytoliqV
R
(Digene Brazil, São Paulo, Brazil)
liquid-based system. The ectocervical and endocervical sam-
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and immersed in Universal Collecting MediumTM vials. The
cervical specimen was stored at 4C until processing for cy-
tology and HPV testing.
Laboratory personnel were blinded to the case-control sta-
tus of the participants. Cervical specimens were centrifuged
at 5,000 rpm for 10 min at 22–24C. Cells were digested with
0.2 mg/ml proteinase K in 50 ll 100 mM NaCl, 10 mM Tris-
HCl pH 8.0, 25 mM EDTA buffer pH 8.0, 0.5% SDS between
2 and 16 hr at 60C and purified. Extracted DNA was tested
for presence of human DNA using a polymerase chain reac-
tion (PCR) protocol for b-globin and for HPV DNA by a
PCR protocol amplifying a highly conserved 450-bp segment
in the L1 viral gene (flanked by primers MY09/11). Typing
of amplified products was performed by hybridization with
individual oligonucleotide probes specific for 27 HPV genital
types 6/11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 44, 45, 51, 52,
53, 54, 56, 57, 58, 59, 66, 68, 73, 82, 83 and 84. The PCR
amplification products were further tested by restriction frag-
ment-length polymorphism (RFLP) analysis of the L1 frag-
ment, to resolve dubious results from the dot-blot hybridiza-
tion and to distinguish among HPV types that could not be
identified by dot-blot hybridization with the specific probes.
This allowed extending the detection range to >40 genital
HPV types, including HPV types 32, 34, 62, 67, 69–72 and
89. Amplified products that hybridized with the generic
probe but not with any of the type-specific probes and that
also did not produce a recognizable band pattern in the
RFLP analysis were considered to be positive for HPV of
unknown types.
A cervical exfoliated sample was not available for 43 of
108 (39.8%) invasive cancer cases (the clinical stage distribu-
tion according to the International Federation of Gynecology
and Obstetrics classification among these cases was as fol-
lows: 46%, 14 and 40% for stage I, II and III, respectively).
HPV testing in such cases was done in paraffin-embedded
biopsies. Cellular material was extracted from paraffin sec-
tions in 200–400 ll buffer (50 mM Tris-HCl pH 7.5; 1 mM
de EDTA; 0.5% de Triton X-100) in a microwave oven set at
the highest power no more than 15 sec for 4 times, followed
by centrifugation at 12,000 rpm during 15 min. The sample
was then incubated, centrifuged and treated to extract DNA
as earlier. The quality of DNA extracts was ascertained by
testing for human b-globin by PCR. Specimens were tested
more than once until a definitive result was obtained. Sepa-
rate assays were performed with a diluted sample in case the
first amplification resulted negative for b-globin. Paraffin-em-
bedded samples were tested by the GP5þ/6þ general primer
system which amplifies a conserved 150-bp segment in the
L1 viral gene. Typing of amplified products was performed as
described earlier.
Definition of variables
Serum concentrations of total carotene, tocopherols and reti-
nol, dietary nutrients, food groups and other continuous vari-
ables, except age, were categorized into tertiles or quartiles
based on their distribution among controls. Ethnicity was
categorized as white and non-White (black women and
mulatto). HPV types were classified as having either high-
risk oncogenic potential or low-risk oncogenic potential.
High-risk types included HPVs 16, 18, 31, 33, 35, 39, 45, 51,
52, 56, 58, 59, 68, 73 and 82.25 HPV status was classified as
per the following 4 hierarchical mutually exclusive categories:
(i) HPV negative, (ii) only positive for low-risk HPV types,
(iii) positive for at least 1 high-risk HPV type except HPV-
16 and HPV-18 and (iv) positive for HPV-16 and/or HPV-
18.
Statistical analysis
Median values and interquartile (IQ) ranges were calculated
for serum micronutrients and dietary intake according to
outcome status. Pearson v2 test was used to examine differ-
ences in proportions and the Mann-Whitney test for differ-
ences in continuous variables between groups. Serum tocoph-
erol measurements were adjusted for total serum cholesterol,
and dietary nutrient intakes were adjusted for total energy by
the residual method.26 Separate unconditional logistic regres-
sion models were used to calculate odds ratios (OR) and 95%
confidence intervals for each of 4 outcomes (CIN 1, CIN2,
CIN3 and invasive cancer) with individuals in the lowest ter-
tile or quartile category of the exposure of interest (serum
tocopherols, total carotene, foods or nutrients) as the referent
group. Tests for linear trend were calculated by assigning the
median value for each exposure category and modeling the
values as a continuous variable. All analyses were adjusted
for age, hospital, ethnicity, education and potential confound-
ers (smoking, sexual debut, lifetime sexual partner and par-
ity) or mediators (HPV status) if their inclusion in any of the
models caused a change in the OR estimate of 10% or more.
Analyses were done in STATA 9.0 (Statacorp, College Sta-
tion, TX).
Results
Figure 1 shows the recruitment of participants. A total of
1,676 women were contacted between March 2003 and May
2005. Among them, 1,447 women completed the study proto-
col (86.3%) with 53 refusals (4.5%; 34 potential cases and 19
potential controls). Among those enrolled, 1,179 women were
eligible for the present study. Overall, 121 participants were
excluded for the present analysis: 64 cases of cervical neopla-
sia were not confirmed on biopsy, 48 were diagnosed with
atypical squamous/glandular cells of undetermined signifi-
cance (ASCUS or AGCUS), and 9 had negative b-globin
exfoliated cervical cells for HPV testing. In total, 453 controls
and four case groups were considered: 140 women diagnosed
with CIN1, 126 with CIN2, 231 with CIN3 and 108 patients
with cervical cancer (of them, 9 were invasive adenocarci-
noma). Overall, 461 cases and 331 controls provided fasting
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The mean ages (SD) were 40.3 (11.4), 35.2 (9.8), 35.1
(10.1), 38.1 (9.7), 46.2 (9.9) years for controls, CIN1, CIN2,
CIN3 and invasive cancer cases, respectively. Most partici-
pants were non-White (68.2%) with a median monthly
income (interquartile ranges, IQ) of USD 58.0 (33.5–105.0).
CIN3 and cancer case groups were more likely to be older,
current smokers, less educated, had lower income, had an
earlier sexual debut, a higher number of sexual partners, and
higher parity (Table 1). Median values (IQ) of number of
lifetime Pap tests were 9 (3.3–17.0), 5 (3.0–12.0), 6 (2.0–
12.5), 4 (2.0–11.0) and 5 (2.0–13.0) for controls, CIN1, CIN2,
CIN3 and invasive cancer cases, respectively. HPV positivity,
mainly HPV16 and/or HPV18, was higher in cases than in
controls. Among cases of invasive cancer, positivity for HPV
in paraffin-embedded biopsies was 76.7% (n ¼ 43) and in
exfoliated cervical cells was 89.2% (n ¼ 65) (v2 test, p ¼
0.081).
Table 2 shows the concentrations of serum micronutrients
and dietary intake for all groups. Missing values for dietary
information were due to 2 participants without dietary data
and 5 women with implausible values. Total energy and food
intake were similar across study groups, except for total fruit
and juices and dark green and deep yellow vegetables and
fruit which were lower among CIN1 and CIN3 cases relative
to controls and other case groups. Serum concentrations of
total carotene and lycopene were lower for all case groups,
and serum tocopherols were lower among CIN cases than
among controls and cancer cases.
Any dietary and serum biomarker was associated with the
lowest CIN grade, except for serum lycopene. Higher serum
concentrations of lycopene were negatively associated with
CIN1. In crude analysis, the OR (95%CI) for the highest
compared to the lowest tertile was 0.52 (0.29–0.94, p for
trend ¼ 0.05). After adjusting for confounding variables (age,
hospital, ethnicity, schooling, smoking, sexual debut, lifetime
number of sexual partner and parity) the estimated relative
risk was 0.56 (0.31–1.03, p for trend ¼ 0.06). After adjusting
for covariates and HPV status, the OR (95%CI) was 0.64
(0.34–1.21) for the second and 0.53 (0.27–1.00, p for trend ¼
0.05) for the highest tertile when compared to the lowest
(data not shown).
Table 3 presents results from three multiple logistic
regression models for the association between serum micro-
nutrients and dietary intake and CIN2. In crude analysis,
increasing tertiles of serum a-tocopherol and total carotene
were associated with a decreasing risk of CIN2. After multi-
ple adjustments, a trend for decreasing risk of CIN2 with
increasing tertiles was noted for serum total carotene.
Table 4 presents results for the association between serum
micronutrients and CIN3. Increasing serum concentrations of
a- and c-tocopherols were inversely associated with CIN3
risk; the adjusted OR for the highest compared to the lowest
quartile of a-tocopherol was 0.36 (95%CI, 0.18–0.74; p for
trend ¼ 0.004), and for the highest versus lowest tertile of c-
tocopherol was 0.51 (95%CI, 0.28–0.91; p for trend ¼ 0.02)
after adjusting for confounding variables. When we addition-
ally adjusted for HPV status, the strength of the associations
was maintained for both tocopherols (p for trend ¼ 0.03). In
analyses restricted to oncogenic HPV positive women (high-
risk HPV including HPV16/HPV 18), serum a-tocopherol
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21–30 108 (23.8) 55 (39.3) 50 (39.7) 56 (24.2) 6 (5.6)
31–40 113 (25.0) 44 (31.4) 45 (35.7) 86 (37.2) 28 (25.9)
41–50 143 (31.6) 32 (22.9) 18 (14.3) 62 (26.8) 36 (33.3)
51–65 89 (19.6)a 9 (6.4)a 13 (10.3)a 27 (11.8)b 38 (35.2)c
Ethnicity
White 176 (38.9) 40 (28.6) 33 (26.2) 54 (23.4) 29 (26.9)
Non-White 277 (61.1)a 100 (71.4)a 93 (73.8)a 177 (76.6)a 79 (73.1)a
Years of schooling
11 153 (33.8) 48 (34.3) 31 (24.6) 36 (15.6) 7 (6.5)
6–10 135 (29.8) 50 (35.7) 43 (34.1) 71 (30.7) 24 (22.2)
5 165 (36.4)a 42 (30.0)a 52 (41.3)a 124 (53.7)b 77 (71.3)c
Income per person, USD/month1
100 150 (33.1) 38 (27.1) 33 (26.2) 42 (18.2) 22 (20.4)
51–99 150 (33.1) 38 (27.1) 40 (31.7) 69 (29.9) 28 (25.9)
50 150 (33.1)a 61 (43.6)b 51 (40.5)a 115 (49.8)b 58 (53.7)b
Cigarette smoking1
Never 261 (57.6) 73 (52.1) 59 (46.8) 66 (28.6) 48 (44.4)
Former, 5.80 pack-year 47 (10.4) 16 (11.4) 14 (11.1) 18 (7.9) 5 (4.6)
Former, 5.81 pack-year 46 (10.1) 10 (7.1) 8 (6.3) 28 (12.1) 14 (13.0)
Current
 4.80 pack-year 24 (5.3) 15 (10.7) 11 (8.7) 22 (9.5) 4 (3.7)
4.81–14.0 pack-year 33 (7.3) 14 (10.0) 22 (17.5) 53 (22.9) 17 (15.7)
>14 pack-year 42 (9.3)a 12 (8.7)a 11 (8.7)a 44 (19.0)b 19 (17.6)c
Ageat first vaginal intercourse (years)1
21 121 (26.7) 31 (22.1) 19 (15.1) 16 (6.9) 8 (7.4)
19–20 141 (31.1) 36 (25.7) 34 (27.0) 58 (25.1) 30 (27.8)
16–18 119 (26.3) 42 (30.0) 36 (28.6) 74 (32.0) 41 (38.0)
15 72 (15.9)a 31 (22.1)a 35 (27.8)a 82 (35.5)b 29 (26.8)b
Lifetime number of sexual partners1
1 191 (42.2) 40 (28.6) 28 (22.2) 39 (16.9) 24 (22.2)
2–3 181 (40.0) 67 (47.8) 61 (48.4) 105 (45.5) 31 (28.7)
4 80 (17.7)a 33 (23.6)a 37 (29.4)a 86 (37.2)b 53 (49.1)a
Number of pregnancies
Never 57 (12.6) 16 (11.4) 13 (10.3) 10 (4.3) 4 (3.7)
1 82 (18.1) 28 (20.0) 16 (12.7) 20 (8.6) 10 (9.2)
2 111 (24.5) 30 (21.4) 33 (26.2) 24 (10.5) 18 (16.7)
3 90 (19.9) 34 (24.3) 21 (16.7) 59 (25.5) 12 (11.1)
4 113 (24.9)a 32 (22.9)a 43 (34.1)a 118 (51.1)b 64 (59.3)c
Oral contraceptive use
Never 112 (24.7) 27 (19.3) 27 (21.4) 60 (26.0) 30 (27.8)
Former 261 (57.6) 71 (50.7) 68 (54.0) 119 (51.5) 70 (64.8)
Current 80 (17.7)a 42 (30.0)a 31 (24.6)a 52 (22.5)a 8 (7.4)b
HPV status
HPV negative 324 (71.5) 47 (33.6) 20 (15.9) 15 (6.5) 17 (15.7)
Positive only for low-risk HPV 24 (5.4) 4 (2.8) 7 (5.5) 3 (1.3) 5 (4.6)
Positive for at least one high-risk type except HPV-16/HPV-18 45 (9.9) 43 (30.7) 31 (24.6) 52 (22.5) 15 (14.0)
Positive for HPV-16 and/or HPV-18 60 (13.2)a 46 (32.9)a 68 (54.0)b 161 (69.7)c 71 (65.7)b
1Totals do not coincide due to missing values for some variables. Values in the same row with different superscript letters are significantly different
in percentages, p  0.05.
concentrations were negatively associated with CIN3
[adjusted OR (95%CI): 0.44 (0.18–1.08), p for trend ¼ 0.04]
(data not shown). Serum lycopene, dietary intakes of dark
green and deep yellow vegetables/fruit, and carrots were
inversely associated with CIN3 [adjusted OR (95%CI): 0.49
(0.28–0.88), 0.52 (0.31–0.87) and 0.56 (0.34–0.92), respec-
tively], when participants in the highest tertiles were com-
pared to those in the lowest tertiles after adjusting for con-
founding. These associations were not considerably different
after additional adjustment for HPV status (p for trend ¼
0.05). When the analysis was restricted to HPV16 and/or
HPV18-positive women, the most oncogenic types for cervi-
cal cancer, and inverse association was observed between
serum lycopene, total carotene and CIN3: adjusted OR
(95%CI) for the highest compared to the lowest tertile was
0.19 (0.05–0.70; p for trend ¼ 0.01), 0.26 (0.08–0.91; p for
trend ¼ 0.02, respectively (data not shown).
Associations between selected serum micronutrients and
cervical cancer are reported in Table 5. Only increasing se-
rum concentrations of lycopene were negatively associated
with the risk of cancer after adjusting for confounding varia-
bles and HPV status. The adjusted OR (95% CI) for the
highest versus the lowest tertile was 0.18 (0.06–0.52; p for
trend ¼ 0.002) for lycopene.
We conducted an additional analysis among controls to
investigate factors associated with HPV positivity. Dietary
intakes of dark green vegetables were inversely associated
with HPV positivity [adjusted OR (95%CI): 0.51 (0.31–0.83),
p for trend ¼ 0.007] when comparing participants above ver-
sus below median values, adjusting for the same covariates
(age, hospital, ethnicity, education, sexual debut, lifetime sex-
ual partners and parity).
In an additional analysis we compared cases with different
lesion grades to study potential predictors of progression. For
precision, we categorized markers as either below or above
the median values. A high total carotene concentration was
associated with reduced odds of cancer risk when compared
to CIN1 [adjusted OR (95%CI): 0.40 (0.16–0.98) and CIN3
cases [adjusted OR (95%CI): 0.43 (0.21–0.88). A high serum
lycopene concentration was negatively associated with pro-
gression from CIN2 to cancer [adjusted OR (95%CI): 0.44
(0.19–0.99). For dietary intake, dark green and deep yellow
vegetables and fruit reduced the risk of progression from
CIN2 to CIN3: [adjusted OR (95%CI): 0.44 (0.26–0.75) (data
not shown).
Discussion
In this case-control study we examined associations between
several nutritional markers and different grades of cervical
lesions while controlling for HPV status. Nutritional status
was assessed by a validated food frequency questionnaire and
biochemical measurements. Our findings suggest that (i) se-
rum lycopene concentration was associated with reduced risk
of cervical dysplasia and invasive cancer, (ii) serum tocopher-







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































708 Diet, serum micronutrients and cervical neoplasia
Int. J. Cancer: 126, 703–714 (2010) VC 2009 UICC
empirical adjustment for confounding variables and HPV sta-
tus. These findings were consistent in restricted case-control
analysis using only HPV-16 and/or HPV-18 positive women
for serum lycopene, total carotene and CIN3.
Previous epidemiologic studies found that blood lycopene
levels were inversely associated with risk of CIN1, CIN2 and
CIN3 with risk reductions ranging from 40 to 72% for higher
serum levels after adjusting for confounding variables and
HPV.12,15,17,26 However, only 1 study showed a significant
linear trend.17
An important limitation of our hospital-based case-control
study is the potential low efficiency in covariate adjustment
because of the lack of age and ethnicity-matching in the
design. We adjusted for these variables in the models, but it
is difficult to ascertain that we succeeded in completely con-
trolling for the confounding effect of these factors since age,
Table 3. Odds ratios (OR) and corresponding 95% confidence intervals (CI) among cases of CIN2 and controls according to tertiles of serum






Model 1 Model 2 Model 3
Serum concentrations (lmol/l)
a-tocopherol1
0.18–0.61 56 (58.9) 114 (34.9) 1.00 1.00 1.00
0.61–0.82 19 (20.0) 108 (33.0) 0.38 (0.21–0.69) 0.43 (0.22–0.84) 0.39 (0.18–0.84)
0.82–1.69 20 (21.1) 105 (32.1) 0.45 (0.25–0.81) 0.61 (0.30–1.21) 0.57 (0.26–1.24)
p for trend 0.003 0.07 0.08
c-tocopherol1
0.32–0.96 45 (47.4) 112 (34.3) 1.00 1.00 1.00
0.96–1.14 17 (17.9) 109 (33.3) 0.40 (0.21–0.75) 0.40 (0.19–0.84) 0.34 (0.15–0.80)
1.14–1.82 33 (34.7) 106 (32.4) 0.87 (0.51–1.51) 1.10 (0.59–2.07) 0.92 (0.45–1.86)
p for trend 0.52 0.92 0.70
Total carotene
0.07–0.60 51 (53.7) 119 (36.0) 1.00 1.00 1.00
0.60–1.09 25 (26.3) 101 (30.5) 0.63 (0.36–1.11) 0.82 (0.42–1.58) 0.96 (0.45–2.00)
1.09–6.23 19 (20.0) 111 (33.5) 0.45 (0.24–0.83) 0.61 (0.30–1.24) 0.70 (0.32–1.53)
p for trend 0.008 0.17 0.40
Lycopene
0.08–0.78 49 (51.6) 107 (32.3) 1.00 1.00 1.00
0.78–1.39 18 (18.9) 106 (32.0) 0.43 (0.23–0.80) 0.51 (0.25–1.03) 0.39 (0.17–0.87)
1.39–6.30 28 (29.5) 118 (35.6) 0.63 (0.36–1.10) 0.84 (0.45–1.58) 0.74 (0.36–1.52)
Dietary intakes (g/day) 0.08 0.52 0.36
Dark green and deep yellow vegetables and fruits
0–16.7 46 (36.8) 148 (32.8) 1.00 1.00 1.00
16.7–45.7 42 (33.6) 151 (33.5) 0.95 (0.58–1.55) 1.03 (0.60–1.79) 1.08 (0.59–1.99)
45.7–499.0 37 (29.6) 152 (33.7) 0.93 (0.56–1.54) 1.26 (0.71–2.24) 1.38 (0.72–2.64)
p for trend 0.78 0.45 0.34
Carrots
0–69.0 46 (36.8) 152 (33.7) 1.00 1.00 1.00
69.0–203.0 44 (35.2) 148 (32.8) 1.02 (0.63–1.66) 1.29 (0.75–2.23) 1.36 (0.73–2.52)
203.0–1321.0 35 (28.0) 151 (33.5) 0.84 (0.51–1.40) 1.24 (0.70–2.21) 1.23 (0.64–2.36)
p for trend 0.52 0.44 0.50
Model 1: adjusted for age groups (21–30, 31–40, 41–50, and 51–65 years). Model 2: adjusted for age groups, hospital, ethnicity (white,
non–white), schooling ( 5, 6–10,  11 y), smoking (never, former 5.80 pack-year, former 5.81 pack-year, current 4.80 pack-year, current
4.81–14.0 pack-year, current >14 pack-year), sexual debut (21, 19–20, 16–18, 15 years), life time sexual partner (1, 2–3 and 4 partners),
and parity (0, 1, and 2 pregnancies). Model 3: model 2 and adjusted additionally for HPV status (negative for HPV, low-risk HPV, high-risk HPV
except HPV16/HPV18, HPV16 and/or 18).
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ethnicity, socio-economic status, high parity, smoking, long-
term oral contraceptive use are correlated with nutritional sta-
tus.10,11 Another concern is related to the study design, which
does not permit assessing whether the identified relations
resulted from a direct causal influence of nutritional status on
risk or because of systemic effects that the disease had on the
patients possibly leading to loss of nutrients. This possible
effect may seem to be suggested in Table 2 as serum concen-
trations decrease by disease severity for total carotene, lyco-
pene and a-tocopherol (p for trend < 0,001). However, the
Table 4. Odds ratios (OR) and corresponding 95% confidence intervals (CI) among cases of CIN3 and controls according to serum







Model 1 Model 2 Model 3
Serumconcentrations (lmol/l)
a-tocopherol1 (quartiles)
0.18–0.55 84 (45.4) 84 (25.7) 1.00 1.00 1.00
0.55–0.73 41 (22.2) 90 (27.5) 0.41 (0.25–0.68) 0.47 (0.25–0.88) 0.60 (0.26–1.35)
0.73–0.90 40 (21.6) 75 (22.9) 0.49 (0.30-0.79) 0.55 (0.29–1.01) 0.52 (0.22–1.22)
0.90–1.69 20 (10.8) 78 (23.9) 0.26 (0.15–0.47) 0.36 (0.18–0.74) 0.40 (0.16–1.01)
p for trend <0.001 0.004 0.03
c-tocopherol1 (tertiles)
0.32–0.96 98 (53.0) 112 (34.3) 1.00 1.00 1.00
0.96–1.14 46 (24.8) 109 (33.3) 0.47 (0.30–0.73) 0.42 (0.23–0.75) 0.44 (0.20–0.95)
1.14–1.82 41 (22.2) 106 (32.4) 0.46 (0.29–0.73) 0.51 (0.28–0.91) 0.45 (0.21–0.97)
p for trend <0.001 0.01 0.03
Total carotene (tertiles)
0.07–0.60 107 (58.2) 119 (36.0) 1.00 1.00 1.00
0.60–1.09 40 (21.7) 101 (30.5) 0.47 (0.30–0.75) 0.46 (0.25–0.84) 0.48 (0.23–1.05)
1.09–6.23 37 (20.1) 111 (33.5) 0.39 (0.25–0.62) 0.53 (0.29–0.96) 0.57 (0.25–1.26)
p for trend <000.1 0.01 0.10
Lycopene (tertiles)
0.08–0.78 96 (51.9) 107 (32.3) 1.00 1.00 1.00
0.78–1.39 48 (25.9) 106 (32.0) 0.54 (0.35–0.85) 0.61 (0.35–1.06) 0.47 (0.22–0.99)
1.39–6.30 41 (22.2) 118 (35.7) 0.43 (0.27–0.68) 0.49 (0.28–0.88) 0.48 (0.22–1.04)
p for trend <0.001 0.01 0.05
Dietary intakes (g/day, tertiles)
Dark green and deep yellow vegetables and fruits
0–16.7 118 (51.3) 148 (32.8) 1.00 1.00 1.00
16.7–45.7 68 (29.6) 151 (33.5) 0.59 (0.40–0.86) 0.66 (0.41–1.06) 0.77 (0.43–1.39)
45.7–499.0 44 (19.1) 152 (33.7) 0.39 (0.25–0.59) 0.52 (0.31–0.87) 0.52 (0.27–1.00)
p for trend <0.001 0.01 0.05
Carrot
0–69.0 113 (49.1) 152 (33.7) 1.00 1.00 1.00
69.0–203.0 68 (29.6) 148 (32.8) 0.64 (0.43–0.93) 0.77 (0.48–1.23) 0.87 (0.48–1.59)
203.0–1321.0 49 (21.3) 151 (33.5) 0.46 (0.31–0.70) 0.56 (0.34–0.92) 0.50 (0.27–0.95)
p for trend <0.001 0.02 0.04
Model 1: adjusted for age groups (21–30, 31–40, 41–50, and 51–65 years). Model 2: adjusted for age groups, hospital, ethnicity (White,
non-White), schooling (5, 6–10,  11y), smoking (never, former 5.80 pack-year, former 5.81 pack-year, current 4.80 pack-year, current 4.81–
14.0 pack-year, current >14 pack-year), sexual debut (21, 19–20, 16–18, 15 years), lifetime sexual partner (1, 2–3 and 4 partners), and
parity (0, 1and 2 pregnancies). Model 3: model 2 and adjusted additionally for HPV status (negative for HPV, low-risk HPV, high-risk HPV except
HPV16/HPV18, HPV16 and/or 18).
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fact that the associations we observed increased in strength
across the spectrum of lesion grades suggests that a true influ-
ence of the biomarkers on carcinogenesis is more likely to be
correct interpretation, since systemic effects are essentially
minimal for the pre-invasive stages of cervical neoplasia.
Cohort studies that assessed clearance of oncogenic HPV
infection have reported faster clearance for those in the high-
est versus the lowest levels of serum lycopene.27,28 However,
in the Ludwig-McGill cohort study, also conducted in São
Paulo, women in the highest tertile of cis-lycopene (most
common isomer in blood) concentrations were twice as likely
than those in the lowest tertile to have a persistent oncogenic
HPV infection,29 which may have been due to the need in
the latter study of using average concentrations from multiple
time points including samples collected after the infection
had initiated.
Epidemiologic studies have found that higher blood b-car-
otene concentrations were protective against all CIN grades
with risk reductions of 30–54%.15–17 In our study, total se-
rum carotene concentration was negatively associated with
progression from CIN1 to cancer, and from CIN3 to cancer
after adjusting for confounding variables and HPV status. In
prospective studies, clearance of transient high-risk HPV
infection was strongly associated with plasma b-carotene lev-
els.28 Our observations are consistent with the latter; it is
possible that the effect of total carotene on cervical cancer
may be exerted mostly in the early stages of carcinogenesis
via mediation of HPV infection persistence.
In previous case-control studies, higher circulating levels
of a-tocopherol were associated with a 50–70% risk reduction
for CIN of all grades after adjusting for age, ethnicity,
income, smoking, alcohol and HPV infection.15–16 Two other
studies failed to find any association between a-tocopherol
and cervical dysplasia possibly due to lack of adjustment for
blood cholesterol—a strongly correlated nutrient necessary
for the transport of serum vitamin E.17–18 For blood c-
Table 5. Odds ratios (OR) and corresponding 95% confidence intervals (CI) among cases of invasive cervical cancer and controls according






Model 1 Model 2 Model 3
Serum concentrations (lmol/l)
a-tocopherol1
0.18–0.61 35 (43.8) 114 (34.9) 1.00 1.00 1.00
0.61–0.82 19 (23.8) 108 (33.0) 0.54 (0.29–1.00) 0.89 (0.40–1.99) 0.67 (0.25–1.74)
0.82–1.69 26 (32.5) 105 (32.1) 0.70 (0.39–1.27) 1.74 (0.79–3.86) 1.49 (0.59–3.74)
p for trend 0.22 0.20 0.48
Lycopene
0.08–0.78 48 (58.5) 107 (32.3) 1.00 1.00 1.00
0.78–1.39 23 (28.1) 106 (32.0) 0.42 (0.24–0.76) 0.66 (0.30–1.45) 0.56 (0.24–1.33)
1.39–6.30 11 (13.4) 118 (35.7) 0.17 (0.08–0.35) 0.37 (0.15–0.93) 0.18 (0.06–0.52)
p for trend <0.001 0.03 0.002
Total carotene
0.07–0.60 53 (64.6) 119 (36.0) 1.00 1.00 1.00
0.60–1.09 18 (22.0) 101 (30.5) 0.34 (0.18–0.63) 0.46 (0.21–1.03) 0.45 (0.18–1.18)
1.09–6.23 11 (13.4) 111 (33.5) 0.19 (0.09–0.38) 0.52 (0.22–1.23) 0.46 (0.17–1.24)
p for trend <0.001 0.06 0.08
Dietary intakes (g/day)
Dark green and deep yellow vegetables and fruits
0–16.7 48 (44.4) 148 (32.8) 1.00 1.00 1.00
16.7–45.7 26 (24.1) 151 (33.5) 0.51 (0.30–0.88) 0.74 (0.34–1.48) 0.85 (0.39–1.85)
45.7–499.0 34 (31.5) 152 (33.7) 0.62 (0.37–1.00) 1.23 (0.63–2.42) 1.55 (0.73–3.29)
p for trend 0.06 0.58 0.27
Model 1: adjusted for age groups (21–30, 31–40, 41–50, and 51–65 y). Model 2: adjusted for age groups, hospital, ethnicity (White, non-White),
schooling (5, 6–10,  11y), smoking (never, former 5.80 pack-year, former 5.81 pack-year, current 4.80 pack-year, current 4.81–14.0
pack-year, current >14 pack-year), sexual debut (21, 19–20, 16–18, 15 y), lifetime sexual partner (1, 2–3 and 4 partners),and parity (0, 1 and
2 pregnancies). Model 3: model 2 and adjusted also for HPV status (negative for HPV, low-risk HPV, high-risk HPV except HPV16/HPV18,
HPV16and/or 18).
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tocopherol no significant association was found in multiple
models.13 Interestingly, however, Giuliano et al.30 found that
serum concentrations of a- and c-tocopherol were signifi-
cantly lower in women with persistent HPV. Comparable
results for a-tocopherol but not for c-tocopherol were found
in two other studies.28,29
Serum carotenoids and tocopherols may influence risk of
cervical neoplasia via antioxidant activity scavenging reactive
oxygen species (ROS), thus reducing toxic effects to cell
membranes, cellular proteins, and nucleic acids.31 Polyunsa-
turated fatty acids in cell membranes can be oxidized by
ROS, which affects the fluidity and integrity of the membrane
with consequent changes in the distribution and function of
cellular receptors.32 Additional anti-inflammatory mecha-
nisms have been reported for tocopherols, such as inhibitory
protein kinase C (PKC) activity, inhibitory activity of
enzymes involved in eicosanoid biosynthesis, and in inhibi-
ting COX-2-mediated biosynthesis of PGE2.
33
In this investigation, we did not find any association
between serum retinol and CIN or cervical cancer, in contrast
to previous studies.16–18 On the other hand, we found that
increased dietary intake of dark green and deep yellow vege-
tables and fruit, and carrots, which are important dietary
sources of a-carotene, b-carotene, b-cryptoxanthin and
lutein, were negatively associated with CIN3.
There is growing evidence that high intake of foods rich
in b-carotene and lutein have an important role on immune
response possibly acting against persistence of HPV infection.
Giuliano et al.33 found a reduced risk of HPV persistence
among those with a high consumption frequency of papaya
and orange. In our study, intake of fat group and saturated
fatty acid were positively associated with HPV infection
probably reflecting participants’ lifestyle since these food
groups were inversely correlated with fruit intake (Spearman
correlation coefficient between fat intake and fruit and fruit
juice intake ¼ -0.17, p < 0.001).
Additional limitations that apply to case-control studies
should be considered when interpreting our findings. Inaccu-
rate dietary measurement could potentially have influenced
our observed associations. Random errors in dietary measures
more likely would have accounted for biases towards the
null, thus attenuating the magnitude of the associations and
their dose-response trends. On the other hand, it has been
reported that case subjects can remember and report their
previous experience differently than control subjects, who are
free of disease. To minimize possible information bias, we
additionally analyzed serum micronutrients, such as circulat-
ing carotenoids, which has been considered a good biomarker
of fruit and vegetables consumption.34 Another potential li-
mitation in our study is related to HPV testing in paraffin-
embedded biopsies used in around 40% of cancer cases. A
higher proportion of late stage disease was observed among
women whose HPV status was diagnosed from biopsies (v2
test, p ¼ 0.01). The prevalence of HPV infection was lower
(although not significantly) in biopsy samples when com-
pared to exfoliated cervical cells. The failure to detect HPV
DNA in 10/43 (23.3%) may have been due to the absence of
HPV DNA in the analyzed sample or disruption of PCR tar-
get sequence due to viral integration.2 To investigate the
effect of controlling for HPV status determined from differ-
ent samples, we conducted restricted analyses considering
only HPV status based on exfoliated cervical cells or on biop-
sies. The ORs for invasive cancer were statistically compara-
ble across HPV sampling sources for serum lycopene. How-
ever, the same restricted analyses for total serum carotene
indicated a significant negative trend in the association only
among HPV identified using biopsies (data not shown).
Although an effect from misclassification of HPV status can-
not be ruled out we were reassured that, apart from a loss of
precision, the directionality of the associations were main-
tained, irrespective of sample source.
In conclusion, in this case-control study conducted in a
country with a high incidence of cervical cancer we found
strong inverse associations between serum lycopene and toco-
pherols as well as dietary intake of dark green and deep yel-
low vegetables and fruit and CIN and invasive cancer risks.
Our findings corroborate previous epidemiologic evidence
that antioxidants status may reduce risk of cervical neoplasia.
Therefore, in addition to secondary prevention by screening
and treatment of CIN, a balanced diet with an emphasis on
antioxidant-rich fruit and vegetables may be an important
preventive component against development of cervical cancer
in most populations. Future research is needed to determine
if serum antioxidants are associated in the early stage of car-
cinogenesis, in the persistence of incident oncogenic HPV
infection, CIN 1 and CIN2.
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